139 related articles for article (PubMed ID: 34170085)
21. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
[TBL] [Abstract][Full Text] [Related]
22. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
Meng Z; Lu J; Wu H; Zhao Y; Luo Y; Gao J; Zhu Q; Jiang Y; Li W; Liang Z
Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026
[TBL] [Abstract][Full Text] [Related]
23. Value of
Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
[TBL] [Abstract][Full Text] [Related]
24. Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up.
Achille G; Garrisi VM; Russo S; Guastamacchia E; Giagulli VA; Schirosi L; Daniele A; Tufaro A; Cafagna V; Centrone M; Simone G; Abbate I; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):213-218. PubMed ID: 28558632
[TBL] [Abstract][Full Text] [Related]
25. Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis.
Chitikova Z; Pusztaszeri M; Makhlouf AM; Berczy M; Delucinge-Vivier C; Triponez F; Meyer P; Philippe J; Dibner C
Oncotarget; 2015 May; 6(13):10978-93. PubMed ID: 25868389
[TBL] [Abstract][Full Text] [Related]
26. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract][Full Text] [Related]
27. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C
Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
[TBL] [Abstract][Full Text] [Related]
28. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid carcinoma: an easy fine needle aspiration biopsy diagnosis?
Dušková J; Tretiník P
Acta Cytol; 2011; 55(2):120-30. PubMed ID: 21325795
[TBL] [Abstract][Full Text] [Related]
31. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.
Sapio MR; Guerra A; Posca D; Limone PP; Deandrea M; Motta M; Troncone G; Caleo A; Vallefuoco P; Rossi G; Fenzi G; Vitale M
Endocr Relat Cancer; 2007 Dec; 14(4):1089-97. PubMed ID: 18045960
[TBL] [Abstract][Full Text] [Related]
32. Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
Buryk MA; Simons JP; Picarsic J; Monaco SE; Ozolek JA; Joyce J; Gurtunca N; Nikiforov YE; Feldman Witchel S
Thyroid; 2015 Apr; 25(4):392-400. PubMed ID: 25627462
[TBL] [Abstract][Full Text] [Related]
33. Thyroid Microcalcifications in the Absence of Identifiable Nodules and Their Association With Thyroid Cancer.
Whittle C; García M; Horvath E; Slater J; Carrasco C
J Ultrasound Med; 2019 Jan; 38(1):97-102. PubMed ID: 29781213
[TBL] [Abstract][Full Text] [Related]
34. Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound.
Hwang S; Shin DY; Kim EK; Yang WI; Byun JW; Lee SJ; Kim G; Im SJ; Lee EJ
Yonsei Med J; 2015 Sep; 56(5):1338-44. PubMed ID: 26256977
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy.
Kim DW; Jeon SJ; Kim CG
Endocrine; 2012 Oct; 42(2):399-403. PubMed ID: 22350587
[TBL] [Abstract][Full Text] [Related]
36. Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.
Chain K; Legesse T; Heath JE; Staats PN
Cancer Cytopathol; 2019 Aug; 127(8):501-513. PubMed ID: 31150162
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of the Follicular Variant of Papillary Thyroid Carcinoma From Classic Papillary Thyroid Carcinoma: An Ultrasound Analysis and Complement to Fine-Needle Aspiration Cytology.
Ng SC; Kuo SF; Hua CC; Huang BY; Chiang KC; Chu YY; Hsueh C; Lin JD
J Ultrasound Med; 2018 Mar; 37(3):667-674. PubMed ID: 28880405
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule.
Li F; Pan D; Wu Y; Peng J; Li Q; Gui X; Ma W; Yang H; He Y; Chen J
Diagn Cytopathol; 2019 Sep; 47(9):881-889. PubMed ID: 31211509
[TBL] [Abstract][Full Text] [Related]
39. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
[TBL] [Abstract][Full Text] [Related]
40. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]